Truvian Sciences: Raises More Than $105M in Series C Financing USA

Date:

Share post:

  • Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing
  • The round, which brought total funding to more than $150m to date, led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures
  • Truvian is a healthcare company at the intersection of diagnostics and consumer technology
  • Its automated benchtop system developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood
  • The company also announced a roster of executive and board appointments
  • Former Divisional VP of Automation and Informatics at Abbott, Jay Srinivasan, has joined the company as Chief Product Officer
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.
spot_img

Related articles

Top Cybersecurity Incidents of 2025: Key Lessons for the Fintech Industry

Exploring major cybersecurity breaches and their implications for fintech. Highlights: Overview of significant cybersecurity breaches in 2025.Key lessons learned...

Citigroup Exits Russia with $12 Billion Loss in Operations Sale

A significant move in Citigroup's strategy amidst geopolitical tensions. Highlights: Citigroup announces the sale of its remaining operations in...

Key Fintech Trends to Watch in 2025: Innovations and Opportunities

Discover the major fintech developments shaping the industry in 2025. Highlights: Growing adoption of AI technology in financial services.Increased...

Lloyds to Cease Invoice Financing Services According to FT Reports

A significant shift in Lloyds' financial services strategy amid changing market conditions. Highlights: Lloyds Bank plans to shut its...